Clinical Trials: Past, Present & Glorious Future
and 23rd Bradford Hill Memorial Lecture

A meeting to mark the centenary of the MRC Biostatistics Unit (BSU) jointly organised by the Royal Statistical Society (Medical Section), International Biometric Society (British and Irish Region) and PSI (Statisticians in the Pharmaceutical Industry), the London School of Hygiene and Tropical Medicine (LSHTM) and the BSU. Videos now available from LSHTM video channel.

Current Vacancies at MRC Biostatistics Unit

Postdoctoral Statistician | Investigator Statistician (2) | Senior Investigator Statistician | More...

About Us

The BSU is one of the largest groups of biostatisticians in Europe and has established itself as an internationally acclaimed centre for research in biostatistics and a major centre for training and knowledge transfer.

The critical mass of methodological, applied and computational expertise amongst our scientists has ensured an excellent balance between innovation and dissemination of statistical methods, with impact on genuine public health issues.

Insight on research

Stratified Medicine: developing successful partnerships between academia, industry and patients

Personalised-Medicine-pic

The MRC Biostatistics Unit (BSU) is actively pursuing research in the emerging area of stratified medicine. Through our Stratified Medicine Initiative and Clinical Trials Methodology Hub, and with our expertise in statistical genomics, machine learning, complex observational and longitudinal data and evidence synthesis, we are well positioned and already engaged in developing and applying novel []

Improving the quality of analyses in phase II oncology trials assessing the effectiveness of new anti-cancer treatments

(Image credit: Flickr/Phillip Jeffrey)

James Wason, member of Adrian Mander's Adaptive Clinical Trials research group in the MRC Biostatistics Unit (BSU), is working on improving the quality of analyses in phase II oncology trials. Phase II oncology trials are conducted to gather information on the effectiveness of new anti-cancer treatments. This is to decide whether a phase III trial, []

See more Insight on Research

Latest news

See more News

Latest Tweets

MRCBiostatisticsUnit

RT @MRCcomms Overweight and obesity linked to 10 common cancers & over 12,000 cases every year in the UK mrc.io/1pP9B9B #bmi #Cancer


Latest publications


See more Publications